Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Vic.ai Emerges as the Platform of Choice for Private Equity–Backed Companies Focused on Cash Flow, Efficiency, and Scalable Growth
From Vic.ai
Via GlobeNewswire
News headline image
17 Education & Technology Group Inc. Announces Appointment of Chief Financial Officer
From 17 Education & Technology Group Inc.
Via GlobeNewswire
Tickers YQ
News headline image
Andromeda Shatters Identity Silos with the Industry’s First Unified Security Architecture for the Agentic Workforce
From Andromeda Security
Via GlobeNewswire
News headline image
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
From AtaiBeckley Inc.
Via GlobeNewswire
Tickers ATAI
News headline image
Yatiri Bio Enters Exclusive Option to In-License Agreement with Oscotec for Denfivontinib in AML
From Yatiri Bio
Via GlobeNewswire
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Mach Industries Selects Nominal to Run Test Infrastructure for Its Next-Generation Strike and Surveillance Systems
From Nominal, Inc.
Via GlobeNewswire
News headline image
GEN Restaurant Group to Hold Fourth Quarter 2025 Conference Call on Tuesday, March 31, 2026 at 5:00 p.m. ET
From GEN Restaurant Group, Inc.
Via GlobeNewswire
Tickers GENK
News headline image
Jiayin Group Inc. to Release Fourth Quarter and Full Year 2025 Unaudited Financial Results on Tuesday, March 31, 2026
From Jiayin Group Inc.
Via GlobeNewswire
Tickers JFIN
News headline image
Nature Translational Psychiatry Study Reveals Distinct Functional Neuronal Signatures in Patient-Derived Brain Organoids with Itay&Beyond’s Neurotech Platform
From AKAMPION
Via GlobeNewswire
News headline image
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
From Royal Philips
Via GlobeNewswire
Tickers PHG
News headline image
Smithfield Foods Reports Record Fiscal 2025 Results
From Smithfield Foods, Inc.
Via GlobeNewswire
Tickers SFD
News headline image
Hesai Group Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
From Hesai Group
Via GlobeNewswire
Tickers HSAI
News headline image
Henley Opportunity Index 2026: The Citizenship and Residence Options That Unlock the World’s Greatest Opportunities
From HENLEY & PARTNERS GROUP HOLDINGS LTD
Via GlobeNewswire
News headline image
Kandi Technologies Unveils Brand Upgrade to Highlight Intelligent Transformation and Diversified Growth Strategy
From Kandi Technologies Group, Inc.
Via GlobeNewswire
Tickers KNDI
News headline image
Netflix’s Chief Marketing Officer, Marian Lee, Takes Center Stage at Licensing Expo 2026 for an Opening Keynote on the Netflix Effect and Fandom
From Global Licensing Group
Via GlobeNewswire
News headline image
Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Progress on share buyback programme
From ING Group
Via GlobeNewswire
News headline image
SBM Offshore awarded FEED contracts for the Longtail project in Guyana
From SBM Offshore Amsterdam B.V.
Via GlobeNewswire
Tickers SBFFF SBFFY
News headline image
Press release: Availability of the Q1 2026 aide-mémoire
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
CGTN: How Xiongan is evolving into a model for high-quality urban growth
From CGTN
Via GlobeNewswire
News headline image
Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older
From Pharming Group N.V.
Via GlobeNewswire
News headline image
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
From Sanofi Winthrop Industrie
Via GlobeNewswire
News headline image
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers REGN SNY
News headline image
Phonak AI-Powered Hearing Aids Recognized with 2026 Artificial Intelligence Excellence Awards
From Phonak
Via GlobeNewswire
News headline image
Accumulus Technologies Launches the Accumulus Connector, Delivering Live Integration Across Regulatory Systems
From Accumulus Technologies
Via GlobeNewswire
News headline image
BYND DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Beyond Meat, Inc. Investors to Secure Counsel Before Important March 24 Deadline in Securities Class Action - BYND
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers BYND
News headline image
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action – CORT
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers CORT
News headline image
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Concorde International Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIGL
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers CIGL
News headline image
TCPC DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BlackRock TCP Capital Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TCPC
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers TCPC
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.